We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our
Privacy Policy
.
Yes, I accept
Menu
Corporate Members
E-Library
Twitter
Linked In
Facebook
Instagram
Join
MyESTRO
Search Opener
Search for:
About ESTRO
Membership
School
Workshops
Congresses
Science
Education
Advocacy
Corporate Members
E-Library
Home
Congresses
Programme
Other
No date
Session
Other
Session Code:
6034
Session Type:
Digital Poster
Track:
Clinical
Add to
My Programme
Harmonizing the nomenclature in a radiotherapy department: a quality improvement project
Maria do Carmo Lopes
,
Portugal
Presentation Number:
PO-1482
Hypofractionated radiotherapy combined with targeted therapy or immunotherapy: Dutch survey
Evert S.M. van Aken
,
The Netherlands
Presentation Number:
PO-1483
Impact of COVID-19 pandemic on Radiation Oncology practice. An overview of recent higher quality reports
Roberta Carbonara
,
Italy
Presentation Number:
PO-1484
Radiotherapy for Ledderhose disease: long-term efficacy, side effects and patient-rated outcome
Anneke de Haan
,
The Netherlands
Presentation Number:
PO-1485
Should the spleen be an organ at risk?
CAROLINA DE LA PINTA
,
Spain
Presentation Number:
PO-1486
Brachytherapy training survey among Radiation Oncology residents in Europe
Alina Sturdza
,
Austria
Presentation Number:
PO-1487
Patient’s opinion on serving as control in the trials within cohort design – results of a survey
Maaike Verweij
,
The Netherlands
Presentation Number:
PO-1488
Radiotherapy in benign pathology: treatment of lymphorrheas
Verónica Cañón
,
Spain
Presentation Number:
PO-1489
The impact of 68Ga-FAPI-PET/CT on (radio-)oncological management for rare diseases
Stefan Alexander Koerber
,
Germany
Presentation Number:
PO-1490
A comparison of three commercial AI contouring solutions
Konstantinos Ferentinos
,
Cyprus
Presentation Number:
PO-1491
A national survey on oligometastatic disease - perspectives from the clinically working physicians
Mette Felter
,
Denmark
Presentation Number:
PO-1492
Opening the angle: the role played by National Societies for Radiation Oncology during the COVID-19
Josep M Borras
,
Spain
Presentation Number:
PO-1493
Universal testing for SARS-Cov-2 in patients undergoing anticancer treatment.
Andrea Emanuele Guerini
,
Italy
Presentation Number:
PO-1494
Toxicity and effectivity of SBRT of spine metastases in oligometastatic patients using a SIB concept
Maria Waltenberger
,
Germany
Presentation Number:
PO-1495
Superficial X-Ray Therapy in Keloids after surgery: our experience
Maria Cerrolaza
,
Spain
Presentation Number:
PO-1496
Stereotactic and hypofractionated radiotherapy associated with immune checkpoints inhibitors
Dimitri Anzellini
,
Italy
Presentation Number:
PO-1497
Clinical Sensitivity of PROMIS-10 Physical and Mental Quality of Life Domains to Radiation Therapy
Todd DeWees
,
USA
Presentation Number:
PO-1498
1.5T MR-guided daily adaptive radiotherapy: preliminary clinical report of the first 2000 fractions.
MICHELE RIGO
,
Italy
Presentation Number:
PO-1499
Stereotactic Body Radiation Therapy for oligorecurrent thymoma: a monocentric experience
Matteo Sepulcri
,
Italy
Presentation Number:
PO-1500
A Promo from PROMO prospective registry (Pencil beam scanning Proton therapy for Moving tumors)
Srinivas Chilukuri
,
India
Presentation Number:
PO-1501
Stereotactic body radiotherapy of lymph node metastases under MR-guidance
Charlotte Herder-Wagner
,
Germany
Presentation Number:
PO-1502
A systematic review on ultra fractionated chemoradiation
Erica Scirocco
,
Italy
Presentation Number:
PO-1503
The effect of psychiatric comorbidities on treatment decisions for - and survival after radiotherapy
Hajo Boersma
,
The Netherlands
Presentation Number:
PO-1504
Phone call triage for patients admission in a radiotherapy department during COVID 19 pandemic
BIANCA SANTO
,
Italy
Presentation Number:
PO-1505
Psychological impact of COVID 19 pandemic in cancer patients: a cross sectional observational study
BIANCA SANTO
,
Italy
Presentation Number:
PO-1506
Clinical outcomes of bone stereotactic body radiotherapy in patients with oligometastatic cancer
Sofie Harborg Orry Jensen
,
Denmark
Presentation Number:
PO-1507
Nonmalignant skeletal and soft tissue disorders: CT-based contouring atlas for low dose radiotherapy
Beatriz Álvarez
,
Spain
Presentation Number:
PO-1508
Tumours have a sex-relevance to the multifunctional oncoprotein Y-box binding protein-1 (YB-1)
Stefanie Croghan
,
Ireland
Presentation Number:
PO-1509
Electrochemotherapy as a radiosensitizer in preclinical and clinical settings: a systematic review.
Martina Ferioli
,
Italy
Presentation Number:
PO-1510
50 years of radiotherapy research: evolution, trends and lessons for the future
Thomas Berger
,
United Kingdom
Presentation Number:
PO-1511
Daily adaptive MR-guided SBRT for oligometastatic lymph-nodes:feasibility and preliminary experience
MICHELE RIGO
,
Italy
Presentation Number:
PO-1512
Radiation-induced cardiac toxicity for oesophageal or oesophagogastric junctional adenocarcinoma
Lira Pelari
,
Spain
Presentation Number:
PO-1513
Prospective assessment of employees stress during the COVID-19 pandemic
Matthias Guckenberger
,
Switzerland
Presentation Number:
PO-1514
Meta-analysis on the influence of radiation-induced lymphopenia on overall survival in solid tumors.
Pim Damen
,
The Netherlands
Presentation Number:
PO-1515
Prospective evaluation of robotic radiosurgery in Indian patients with oligo-metastases
Ramakrishna Kamath
,
India
Presentation Number:
PO-1516
Which impact of the COVID-19 pandemic on residents training in radiotherapy?
Nejla Fourati
,
Tunisia
Presentation Number:
PO-1517
Effect of bladder filling protocols on bladder volume variation in the age of adaptive radiotherapy
Benjamin Sanderson
,
United Kingdom
Presentation Number:
PO-1518
Efficacy and safety of radiotherapy for Epicondylitis Humeri (EPH)
Tomasz Latusek
,
Poland
Presentation Number:
PO-1519
FAPI-PET/CT improves diagnostic staging and radiotherapy planning of Adenoid Cystic Carcinomas
Mustafa Syed
,
Germany
Presentation Number:
PO-1520
External validation of a prediction model for timely implementation of innovations in radiotherapy.
Rachelle Swart
,
The Netherlands
Presentation Number:
PO-1521
Pseudoprogression versus true progression in glioblastoma patients : A multiapproach analysis
Anne Laprie
,
France
Presentation Number:
PO-1522
Real world outcomes in patients with oligometastases treated with SABR - a single centre experience.
Abiola Fatimilehin
,
United Kingdom
Presentation Number:
PO-1523
On how COVID-19 has affected radiation therapy treatments
Eva Maria Ambroa Rey
,
Spain
Presentation Number:
PO-1524
Does online learning in delineation thrive during a Pandemic? The FALCON group experience.
Chiara Valentini
,
Germany
Presentation Number:
PO-1525
Targeted RT study: preliminary results on acute toxicity of targeted therapies and radiotherapy
Dinah Konnerth
,
Germany
Presentation Number:
PO-1526
Single-institution analysis of cancer patients treated with multiple courses of repeat radiotherapy
Maiwand Ahmadsei
,
Switzerland
Presentation Number:
PO-1527
Mood disorder in cancer patients undergoing radiotherapy during the COVID-19 outbreak
Valerio Nardone
,
Italy
Presentation Number:
PO-1528
HITRIplus project: building a pan-European heavy ion therapy research community
Angelica Facoetti
,
Italy
Presentation Number:
PO-1529
Interobservator variability in GTV contouring in non-spine bone metastases
CAROLINA DE LA PINTA
,
Spain
Presentation Number:
PO-1530
Photon and particle beam radiotherapy for atrial fibrillation: a systematic review
Jessica Franzetti
,
Italy
Presentation Number:
PO-1531
The elephant in the room: teaching OAR delineation in a FALCON workshop in the autosegmentation era
Eleonor Rivin del Campo
,
France
Presentation Number:
PO-1532
Radiotherapy for recurrent keloids: a retrospective review in our centre. Is it worth to treat?
Montserrat Colomer
,
Spain
Presentation Number:
PO-1533
E-Mail Address
Please enter a user name
Password
Cancel
Forgotten Password
Create MyESTRO Account
i
Please log in to add this session to your programme.